info@tulienterprise.com
Call Us : 08045478573
Gefticip 250 Geftinib Tablets
Gefticip 250 Geftinib Tablets

Gefticip 250 Geftinib Tablets

450 INR/Box

Product Details:

  • Indication Non-small cell lung cancer (NSCLC)
  • Salt Composition Gefitinib 250 mg
  • Dosage Form Tablet
  • Feature Targeted EGFR inhibitor, prescription only
  • Ingredients Gefitinib, Excipients
  • Application Oral use in cancer therapy
  • Physical Color/Texture Film-coated, brown-colored tablets
  • Click to View more
X

Gefticip 250 Geftinib Tablets Price And Quantity

  • 450 INR/Box
  • White and maroon strip packaging
  • Keep out of reach of children
  • Prescription required
  • To be sold by retail on the prescription of an Oncologist only
  • 1 strip of 10 tablets
  • Debossed with identification code
  • Oral
  • Cipla Ltd.
  • 250 mg
  • Antineoplastic (antitumor) agent

Gefticip 250 Geftinib Tablets Product Specifications

  • Targeted EGFR inhibitor, prescription only
  • Gefitinib 250 mg
  • Tablet
  • Non-small cell lung cancer (NSCLC)
  • Store below 30C, protect from light and moisture
  • Oral use in cancer therapy
  • Gefitinib, Excipients
  • 24 months
  • Film-coated, brown-colored tablets
  • White and maroon strip packaging
  • Keep out of reach of children
  • Prescription required
  • To be sold by retail on the prescription of an Oncologist only
  • 1 strip of 10 tablets
  • Debossed with identification code
  • Oral
  • Cipla Ltd.
  • 250 mg
  • Antineoplastic (antitumor) agent

Product Description



Gefticip 250 Geftinib Tablets provide a classic and meritorious option for targeted cancer therapy at an affordable price. Supplied by Cipla Ltd., each strip holds 10 film-coated, brown-colored tablets marked for easy identification. Designed as a supreme antineoplastic agent, this prescription medicine features Gefitinib 250 mg in each tablet, validated for oral administration in Non-Small Cell Lung Cancer (NSCLC). Buy online and redeem trusted quality, ensuring efficacy and safety. Store below 30C, protected from light and moisture, with a shelf life of 24 months. Gefticip offers advanced EGFR inhibition for optimal cancer management.

Targeted Oral Therapy for NSCLC

Gefticip 250 Geftinib Tablets are specifically indicated for the management of Non-Small Cell Lung Cancer (NSCLC). With its supreme targeted EGFR inhibitor feature, this classic oral formulation delivers consistent and meritorious results. Suitable for cancer therapy, each tablet is manufactured with high-quality materials and administered under professional supervision. Its application in oncology settings supports effective patient outcomes and streamlined care.


Sample Policy and Premium Packaging

Gefticip 250 Geftinib Tablets are available at the lowest price and come with premium maroon and white strip packaging. Marketed as an export-quality product, each strip contains clear markings for identification. The offer includes sample policies for clinical trials and certifications that guarantee compliance and reliability. Buyers benefit from professional packaging details, making this product ideal for suppliers, traders, and exporters across India.


FAQ's of Gefticip 250 Geftinib Tablets:


Q: How should Gefticip 250 Geftinib Tablets be administered for NSCLC treatment?

A: Gefticip 250 Geftinib Tablets are administered orally, following the dosage instructions and prescription provided by a qualified oncologist.

Q: What is the primary usage of Gefticip 250 Geftinib Tablets?

A: The primary usage of Gefticip 250 is as an antineoplastic agent for the targeted treatment of Non-Small Cell Lung Cancer (NSCLC), leveraging its EGFR inhibitor properties.

Q: When is it appropriate to redeem Gefticip 250 Geftinib Tablets?

A: Gefticip 250 should only be redeemed and used after obtaining a prescription from a certified oncologist, in accordance with cancer treatment protocols.

Q: Where can I buy Gefticip 250 Geftinib Tablets online?

A: Gefticip 250 Geftinib Tablets can be purchased online through authorized suppliers, traders, and exporter platforms based in India, ensuring prescription compliance.

Q: What are the recommended storage instructions for Gefticip 250 tablets?

A: Gefticip 250 tablets should be stored below 30C, protected from light and moisture, and kept out of reach of children for optimal preservation and safety.

Q: What is the benefit of choosing Gefticip 250 Geftinib Tablets for cancer therapy?

A: Gefticip 250 provides targeted inhibition of EGFR pathways, promoting effective control of NSCLC growth with proven safety and reliability from Cipla Ltd.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Oncology Drugs' category



Back to top